Chroma Medicine Announces Data Demonstrating the Benefits of Epigenetic Editing for Multiplex Gene Regulation at ASGCT 2023

/PRNewswire/ -- Chroma Medicine, Inc., (Chroma) a genomic medicine company pioneering single-dose epigenetic editing therapeutics, today presented data...

Related Keywords

Boston ,Massachusetts ,United States ,Vic Myer ,Los Angeles ,Catherine Stehman Breen ,Sahar Abubucker ,Chroma Medicine Inc ,American Society Of Gene Cell Therapy ,American Society ,Cell Therapy ,Annual Meeting ,Senior Director ,Epigenome Editing ,Chroma Medicine ,Health Care Amp Hospitals ,Medical Pharmaceuticals ,Biotechnology ,Clinical Trials Amp Medical Discoveries ,Trade Show News ,